Pregnancy and Maternal Outcomes After Exposure to Risankizumab During Pregnancy: A Multi-Center Experience in the United States
Year: 2025
Type: article
Study design: Observational Study
Source: Inflammatory Bowel Diseases
DOI: 10.1093/ibd/izaf310
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7117321644
